Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar.

Our center carried out an extended study to evaluate the influence of HS016 on sacroiliitis and hip arthritis using magnetic resonance imaging (MRI). One patient of the HS016 group discontinued the study because of sepsis, so 13 and 5 patients who received HS016 or its originator therapy underwent the final MRI examinations. [Extracted from the article]